Success Story: From Prior NIW Approval to Fast EB-1A Success in Biomedical Engineering
Client’s Testimonial:
"Thank you very much!"
On June 10th, 2025, and April 3rd, 2026, we received EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Ph.D. Student in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: June 10th, 2025 (NIW); April 3rd, 2026 (EB1A)
Processing Time: 17 months, 6 days (NIW); 8 days (EB1A) (Premium Processing Requested)
Case Summary:
When a Ph.D. student from China chose to pursue an EB-1A petition, she once again placed her trust in North America Immigration Law Group (Chen Immigration Law Associates). Our firm had previously helped her secure an NIW approval on June 10th, 2025, after a processing time of 17 months and 6 days.
Given her exceptional record in biomedical engineering, we were confident in her eligibility for EB-1A classification. After filing with Premium Processing, her petition was approved in just eight days on April 3rd, 2026—a rapid timeline that reflects the undeniable value of her research. As one independent expert observed, “Through methods that elevate accuracy and ensure clear oversight, [Client] offers solutions that align with the United States’ broader pursuit of innovation and a well-functioning, equitable healthcare infrastructure.”
Proving Extraordinary Influence and Original Contributions
Our client’s research centers on developing advanced artificial intelligence algorithms to improve medical image analysis. To demonstrate her original contributions of major significance, we highlighted several key projects, including work on automating complex anatomical assessments, improving AI-assisted diagnostics for serious illnesses, and developing multimodal medical AI agents for clinical decision support.
Establishing Sustained Acclaim Through Elite Bibliometrics
To satisfy the EB-1A criterion related to authorship of scholarly articles, we presented her extensive and influential publication record. She has authored 15 peer-reviewed journal articles and 16 peer-reviewed conference articles. Her published work has been cited 3,000+ times by researchers worldwide, reflecting an extraordinary level of independent reliance on her findings.
Judging the Work of Peers
Another important EB-1A criterion is participation as a judge of the work of others. We demonstrated this by documenting her substantial peer review activity. She has completed at least 40 reviews for leading journals and conferences, showing that others in the field trust her expertise to evaluate important scientific work.
Securing the Future of U.S. Healthcare AI
We also demonstrated that her continued work in the United States would provide substantial prospective benefit to the nation. Her future plans include advancing AI safety, scalable oversight, and trustworthy healthcare applications involving large language models.
By carefully documenting her top-tier standing and the significant clinical value of her AI innovations, we secured a decisive and rapid EB-1A approval for this exceptional researcher, building on the strong foundation of her earlier NIW success.